VIM and cancer: To investigate the functional implications of vimentin residue C328 in regulating EMT, cancer progression, and stemness, we expressed C328S vimentin in MCF-7 cells, a vimentin-deficient cell line (Usman et al., 2022a) commonly employed to study EMT (Guttilla et al., 2012; Kondaveeti et al., 2015).